Whitehawk Therapeutics, Inc
Price
FilingsNewest: 8-K, Director or officer changeSep 10 →InsidersNo open-market buys. 3 insiders sold $2.6M, 0 of 14 sales on a 10b5-1 plan.→HoldersYu Fan 8.5%Acuta Capital Partners 8.2%QVT Financial 8.1%→Financing →PeersClosest companies: ORIC, SEPN, BCYC→
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- −$79.8Mlast 12 months
- Operating cash flow
- −$107.8Mlast 12 months
- Cash and equivalents
- $85.2Mat the last balance sheet
- Shares outstanding
- 57.0M shareson issue